RBC Capital Markets Matthew Eckler has an unusual background for a Wall Streeter. He didn't attend a top business school, nor did he get a degree in finance or economics. The senior biotech analyst holds a BS in biology and a PhD in molecular biology. And before Eckler nabbed a position at RBC Capital Markets, the investment bank, he was working full-time in a lab studying the effects of certain foods on mice.